can you take glp 1 if you have ulcerative colitis Holding GLP-1 Prior to Colonoscopy: Current Guidelines and Safety GLP-1 Receptor Agonists in Obese

Regulatory Affairs Professionals Society: FDA advisory committee backs two more peptides, rejects one Vote outcomes for Epitalon, Semax, and emideltide, plus regulatory context

Goal: Type 2 diabetes management (A1C reduction) If you prefer once-weekly injections: Semaglutide (Ozempic), tirzepatide (Mounjaro), dulaglutide (Trulicity), or efpeglenatide (Eperzan) If you prefer daily injections: Liraglutide (Victoza) or lixisenatide (Adlyxin) If you prefer oral medication: Semaglutide (Rybelsus) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide (if eligible under shortage provisions) Goal: Weight loss (obesity or overweight with comorbidities) If you want maximum weight loss: Retatrutide (Retara, triple agonist, 24% mean loss) or tirzepatide (Zepbound, dual agonist, 20% to 22% mean loss) If you want proven long-term safety data: Semaglutide (Wegovy, 15% to 17% mean loss, 5+ years post-approval data) If you prefer oral medication: Orforglipron (Orfoglip, 15% mean loss, oral once daily) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide Goal: Both diabetes and weight loss If you have significant obesity (BMI over 35): Tirzepatide (Mounjaro for diabetes indication, Zepbound for obesity indication

J Neurol Neurosurg Psychiatry 65 : 446453

While these medications can be effective for many people, it's important to understand the full picture

Visit our learning page for an in-depth video from our Medical Director explaining these medications, click here: ascendmedical.com/weightlossfaq What is health coaching